We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

98 hedge funds and large institutions have $287M invested in Akcea Therapeutics Inc in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 19

21% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 24

17% more funds holding

Funds holding: 84 → 98 (+14)

7% more capital invested

Capital invested by funds: $268M → $287M (+$19M)

78% less call options, than puts

Call options by funds: $553K | Put options by funds: $2.47M

Holders
98
Holders Change
+14
Holders Change %
+16.67%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
29
Reduced
24
Closed
19
Calls
$553K
Puts
$2.47M
Net Calls
-$1.92M
Net Calls Change
-$1.76M

Top Buyers

Rank Fund Capital Flow
1
GF
Gabelli Funds
New York
+$8.51M
2
Wells Fargo
Wells Fargo
California
+$5.48M
3
CS
Credit Suisse
Switzerland
+$5.35M
4
CS
Candriam SCA
Luxembourg
+$3.47M
5
WIC
Water Island Capital
New York
+$3.09M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$69.4M
2
BG
Bellevue Group
Switzerland
-$15.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.53M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.19M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
26
SG Americas Securities
New York
$1.3M +$477K +33,642 +89%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.28M +$8.78K +619 +0.9%
MFAM
28
Motley Fool Asset Management
Virginia
$1.27M +$66K +4,653 +7%
KPF
29
K2 Principal Fund
Ontario, Canada
$1.07M +$835K +58,853 New
CC
30
Centiva Capital
New York
$907K +$709K +50,000 New
Walleye Capital
31
Walleye Capital
New York
$893K +$698K +49,226 New
Swiss National Bank
32
Swiss National Bank
Switzerland
$818K – – –
PPA
33
Parametric Portfolio Associates
Washington
$812K +$473K +33,339 +292%
VEA
34
Virtus ETF Advisers
New York
$795K +$52.3K +3,690 +9%
AllianceBernstein
35
AllianceBernstein
Tennessee
$780K -$126K -8,900 -17%
Barclays
36
Barclays
United Kingdom
$696K +$62.2K +4,388 +13%
CCM
37
Chicago Capital Management
Illinois
$688K +$538K +37,931 New
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$685K +$63.2K +4,454 +13%
NAM
39
Nexpoint Asset Management
Texas
$670K +$524K +36,953 New
HM
40
Harvest Management
New York
$653K +$511K +36,000 New
PCM
41
Prelude Capital Management
New York
$555K +$434K +30,618 New
ZCM
42
Ziegler Capital Management
Illinois
$500K +$391K +27,567 New
Citadel Advisors
43
Citadel Advisors
Florida
$470K -$1.79M -126,311 -83%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$452K +$1.3K +92 +0.4%
CM
45
Caption Management
Oklahoma
$435K +$213K +15,000 +167%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$408K -$44.8K -3,160 -12%
Jane Street
47
Jane Street
New York
$381K +$298K +21,001 New
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
$362K – – –
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$352K -$51.1K -3,600 -16%
WAM
50
Wolverine Asset Management
Illinois
$348K +$272K +19,194 New
1
2
3 4 5

AKCA Hedge Fund Activity: Q3 2020 in Review

98 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q3 2020, worth a combined $287M — up 7.1% from $268M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new AKCA positions and 19 closed out — a net gain of 14 holders — while 29 added to existing stakes and 24 trimmed.

The largest buyer was Gabelli Funds, opening a new position worth an estimated $8.51M. The largest seller was Fidelity Investments, cutting an estimated $69.4M.

  • 98 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q3 2020, up from 84 in Q2 2020.
  • Funds reported $287M of Akcea Therapeutics Inc stock for Q3 2020, up 7.1% quarter-over-quarter.
  • 33 funds opened new Akcea Therapeutics Inc positions in Q3 2020 and 19 closed out, a net change of +14 holders.
  • The largest Akcea Therapeutics Inc buyer in Q3 2020 was Gabelli Funds, an estimated $8.51M added.
  • The largest Akcea Therapeutics Inc seller in Q3 2020 was Fidelity Investments, an estimated $69.4M sold.

Based on aggregated 13F filings for Q3 2020.